Table 2.
Longitudinal Cohort (n = 32) Characteristics
| Weekly, Monthlya | Yearlya | |
|---|---|---|
| Gender | 19 males, 4 females | 8 males, 1 female |
| Ethnicity | 13 Black (56%), 10 White | 1 Black, 1 Pacific Islander, 7 White |
| Race | 0% Hispanic or Latino | 11% Hispanic or Latino |
| Onset of ARTb | 4 acute, 19 chronic | all chronic |
| Age, years (range)c | 48 (20–66) | 41 (37–58) |
| CD4 nadir (cells/μL) | 334 (9–789) | 190 (10–397) |
| Years of ART suppressiond | 4.8 (0.55–8.4) | 2.4 (1.5–8.2)e |
a
Weekly and monthly enrolled at UNC; yearly enrolled at UCSF.
b
Acute: ART begun within 30 days of negative or discordant HIV antigen test.
c
Age at first T cell measurement.
d
Durable suppression for UNC cohort defined as time from ≤40 copies/mL to first T cell measurement. UCSF (SCOPE cohort) defined as time from ≤500 copies/mL to first T cell measurement.
e
Conservative calculation because of limited clinical data prior to 2001 study enrollment.